Narval

We use Artificial Intelligence to design synthetic Antibody Mimetic Proteins to replace conventional antibodies in novel first-in-class therapeutics.

North America, Mexico TechCrunch Disrupt 2023

Details

  • Founded Date

    2023

  • Industries

    HealthTech, Healthcare Biotech AI/Machine Learning

  • Operating Status

    Open

    Currently Raising
  • Website

    narvalbio.com/

Founders

  • Jose Luis Nuno

    Founder

Have updates? Send them our way!

Sign up for our newsletter